143 related articles for article (PubMed ID: 292536)
1. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia.
Kearney PJ; Light PA; Preece A; Mott MG
Cancer Chemother Pharmacol; 1979; 3(2):117-20. PubMed ID: 292536
[TBL] [Abstract][Full Text] [Related]
2. Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia.
Pinkerton CR; Welshman SG; Bridges JM
Br J Cancer; 1982 Feb; 45(2):300-3. PubMed ID: 6949608
[No Abstract] [Full Text] [Related]
3. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?
Pinkerton CR; Welshman SG; Glasgow JF; Bridges JM
Lancet; 1980 Nov; 2(8201):944-6. PubMed ID: 6107590
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia.
Pearson AD; Mills S; Amineddine HA; Long DR; Craft AW; Chessells JM
Cancer Chemother Pharmacol; 1987; 20(3):243-7. PubMed ID: 3315283
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate absorption in children with acute lymphoblastic leukemia.
Craft AW; Rankin A; Aherne W
Cancer Treat Rep; 1981; 65 Suppl 1():77-81. PubMed ID: 6948609
[TBL] [Abstract][Full Text] [Related]
6. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
[TBL] [Abstract][Full Text] [Related]
7. [Methotrexate levels in the blood and cerebrospinal fluid in children with acute lymphoid leukemia treated with medium doses of methotrexate].
Borsi J; Koós R; Révész T; Schuler D
Orv Hetil; 1984 Oct; 125(44):2667-8, 2671-3. PubMed ID: 6387586
[No Abstract] [Full Text] [Related]
8. Modification of oral methotrexate absorption in children with leukemia.
Mahony MJ; Murphy MS; Wadsworth J; Mott MG
Cancer Chemother Pharmacol; 1984; 12(2):131-3. PubMed ID: 6583027
[TBL] [Abstract][Full Text] [Related]
9. Letter: Altered plasma pharmacokinetics of methotrexate administered intrathecally.
Jacobs SA; Bleyer WA; Chabner BA; Johns DG
Lancet; 1975 Feb; 1(7904):465-6. PubMed ID: 48664
[No Abstract] [Full Text] [Related]
10. Remission induction of meningeal leukemia with high-dose intravenous methotrexate.
Balis FM; Savitch JL; Bleyer WA; Reaman GH; Poplack DG
J Clin Oncol; 1985 Apr; 3(4):485-9. PubMed ID: 3856631
[TBL] [Abstract][Full Text] [Related]
11. High-dose methotrexate in acute lymphocytic leukemia.
Freeman AI; Wang JJ; Sinks LF
Cancer Treat Rep; 1977 Jul; 61(4):727-31. PubMed ID: 267510
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.
Craft AW; Kay H; Lawson DN; McElwain TJ
Br Med J; 1977 Dec; 2(6101):1511-2. PubMed ID: 271033
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia.
Pinkerton CR; Welshman SG; Kelly JG; Shanks RG; Bridges JM
Cancer Chemother Pharmacol; 1982 Dec; 10(1):36-9. PubMed ID: 6961972
[TBL] [Abstract][Full Text] [Related]
14. The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.
Pearson AD; Amineddine HA; Yule M; Mills S; Long DR; Craft AW; Chessells JM
Br J Cancer; 1991 Jul; 64(1):169-73. PubMed ID: 1854617
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect.
Evans WE; Crom WR; Abromowitch M; Dodge R; Look AT; Bowman WP; George SL; Pui CH
N Engl J Med; 1986 Feb; 314(8):471-7. PubMed ID: 3456079
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate in the plasma and cerebrospinal fluid of children treated with intermediate dose methotrexate.
Rechnitzer C; Scheibel E; Hendel J
Acta Paediatr Scand; 1981 Sep; 70(5):615-8. PubMed ID: 6976674
[TBL] [Abstract][Full Text] [Related]
17. High-dose methotrexate as part of remission maintenance therapy for childhood acute lymphocytic leukemia: a Pediatric Oncology Group pilot study.
Frankel LS; Wang YM; Shuster J; Nitschke R; Doering EJ; Pullen J
J Clin Oncol; 1983 Dec; 1(12):804-9. PubMed ID: 6583318
[TBL] [Abstract][Full Text] [Related]
18. Altered central nervous system pharmacology of methotrexate in childhood leukemia: another sign of meningeal relapse.
Morse M; Savitch J; Balis F; Miser J; Feusner J; Reaman G; Poplack D; Bleyer A
J Clin Oncol; 1985 Jan; 3(1):19-24. PubMed ID: 3855310
[TBL] [Abstract][Full Text] [Related]
19. Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexate.
Yap BS; McCredie KB; Benjamin RS; Bodey GP; Freireich EJ
Br Med J; 1978 Sep; 2(6140):791-3. PubMed ID: 279387
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate.
Cohen HJ; Jaffe N
Cancer Chemother Pharmacol; 1978; 1(1):61-4. PubMed ID: 373909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
